EPISODE · Mar 14, 2025 · 7 MIN
Patient-Centered Approaches To Drug Discovery: CEO Sarah Boyce's Vision For Avidity Biosciences
from TD Cowen Insights · host TD Securities
Recorded on 03/05/25TD Cowen senior biotech analyst Ritu Baral speaks with Avidity Bioscience's President and CEO Sarah Boyce from TD Cowen's 45th Annual Health Care Conference. Boyce describes how her desire to meaningfully impact patient lives motivated her to become a biotech CEO, highlighting the vision, resilience, and adaptability needed to build a biotech company. One of 2017's "Fiercest Women in Life Sciences," Boyce shares her thoughts on the importance of a patient-driven mission, integrating patient advocacy and market access as key pillars in Avidity's strategic plan. Her insights are notable for anyone interested in Avidity Biosciences, the biotech industry, or patient-centered approaches to drug discovery. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
NOW PLAYING
Patient-Centered Approaches To Drug Discovery: CEO Sarah Boyce's Vision For Avidity Biosciences
No transcript for this episode yet
Similar Episodes
Jun 4, 2025 ·9m
May 21, 2025 ·11m